Current Edition

Pylote & Pharmaster Sign A Mutual Referencing Agreement To Offer Innovative & Secure Unpreserved Opthalmic Solutions

Pylote, the new player in the green mineral chemical sector, and Pharmaster, a specialist large-scale production and industrialisation of sterile non-injectable liquids and aseptic filling, announced the signature of a mutual referencing agreement to offer to their respective clients innovative & secure unpreserved ophthalmic solutions.
Part of the Synerlab Group, Pharmaster brings its know how in large-scale production and industrialization of sterile non-injectable liquids, with or without preservatives, but also its expertise in the aseptic filling of solutions for ophthalmic application.
Pylote brings its breakthrough innovation, PYCLEARTM PROTECTION that protects patients from all risks of external microbial contamination and preservative side effects, without any change in the industrial process or treatment method. Pylote will provide Pharmaster with “Pylote Added” ready to use 3-parts ophthalmic packaging solutions benefiting from the effects of its 2016 industrial agreement with the leading Greek primary plastic packaging producer Argo.
The “Pylote Added” packaging components to be filled on Pharmaster’s aseptic filling lines will bring real competitive advantages in term of safety and antimicrobial protection in full compliance with worldwide regulations (Eur. Ph., USP, JP. Ph. …) by removing the use of preservatives from ophthalmic products, while eliminating all risk of contamination throughout the total duration of use, thus ensuring patient safety.
“This mutual referencing agreement with Pharmaster is the logical continuum of our 2016 industrial partnership in Europe with Argo to offer the ideal “eco-friendly” industrial and cost effective answer to the health authorities concerned by the adverse effects of preservatives in ophthalmic preparations“ said Loïc Marchin, CEO of Pylote.
“The innovative approach of Pylote has earned Pharmaster’s interest and support to offer improved service and alternative technologies to customers” said Claire Klopfenstein, CEO of Pharmaster.